SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-020076
Filing Date
2023-05-10
Accepted
2023-05-10 07:14:57
Documents
53
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q coya-20230331.htm   iXBRL 10-Q 1393571
2 EX-10.1 coya-ex10_1.htm EX-10 438825
3 EX-31.1 coya-ex31_1.htm EX-31 29863
4 EX-31.2 coya-ex31_2.htm EX-31 29232
5 EX-32.1 coya-ex32_1.htm EX-32 21956
  Complete submission text file 0000950170-23-020076.txt   5939869

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT coya-20230331_cal.xml EX-101.CAL 19604
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT coya-20230331_pre.xml EX-101.PRE 261385
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT coya-20230331_def.xml EX-101.DEF 141759
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT coya-20230331_lab.xml EX-101.LAB 340207
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT coya-20230331.xsd EX-101.SCH 38069
47 EXTRACTED XBRL INSTANCE DOCUMENT coya-20230331_htm.xml XML 907713
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41583 | Film No.: 23904319
SIC: 2834 Pharmaceutical Preparations